Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KL Acquisition CorpKLAQU · Entity 144014 | Director | January 07, 2021 | January 07, 2021 |
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Director | June 10, 2026 | June 12, 2026 |
| Novan, Inc.NOVN · Entity 111882 | Director | June 06, 2023 | June 08, 2023 |
| TENET HEALTHCARE CORPTHC · Entity 2563 | Director | July 27, 2026 | July 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KL Acquisition Corp
Report date January 07, 2021 · Filed January 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-07 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The shares of Class B Common Stock are convertible for shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities - Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-251398) and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Class B Common Stock are convertible for shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities - Founder Shares" in the Issuer's registration statement on Form S-1 (File No. 333-251398) and have no expiration date.
MIMEDX GROUP, INC.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 263,684 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 50,913 · Balance 263,684 F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.
Novan, Inc.
Report date June 06, 2023 · Filed June 08, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,101 |
Reported balance
After 2023-06-07 transaction · row 1
1 source rowRow 1 · 2023-06-07 · Exercise / conversion · Acquired 36,101 · Balance 40,101 F1: The Reporting Person was granted restricted stock units ("RSUs") on June 7, 2022. Each RSU represented a contingent right to receive one share of the Issuer's Common Stock. 36,101 RSUs fully vested on June 7, 2023 and were settled in shares of the Issuer's Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 103,092 |
Reported balance
After 2023-06-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-06 · Grant · Acquired 103,092 · Balance 103,092 F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service as of the vesting date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-06-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-06-07 · Exercise / conversion · Disposed 36,101 · Balance 0 F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4: The RSUs fully vested on June 7, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units ("RSUs") on June 7, 2022. Each RSU represented a contingent right to receive one share of the Issuer's Common Stock. 36,101 RSUs fully vested on June 7, 2023 and were settled in shares of the Issuer's Common Stock.
F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service as of the vesting date.
F4: The RSUs fully vested on June 7, 2023.
TENET HEALTHCARE CORP
Report date July 27, 2026 · Filed July 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,604 |
Reported balance
After 2026-07-27 transaction · row 1
1 source rowRow 1 · 2026-07-27 · Sale · Disposed 5,000 · Balance 31,604 F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $244.95 to $245.29. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $244.95 to $245.29. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TEAM HEALTH HOLDINGS INC.
Report date February 06, 2017 · Filed February 08, 2017
Section 16 reporting ended · disclosed 2017-02-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 1
1 source rowRow 1 · 2017-02-06 · Disposition to issuer · Disposed 19,384 · Balance 0 F1: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-02-06 · Disposition to issuer · Disposed 916 · Balance 0 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F4: These restricted stock units were to vest on May 20, 2017. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-02-06 · Disposition to issuer · Disposed 1,630 · Balance 0 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F5: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the May 21, 2015 grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-02-06 · Disposition to issuer · Disposed 3,320 · Balance 0 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F6: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person.
F4: These restricted stock units were to vest on May 20, 2017.
F5: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the May 21, 2015 grant date.
F6: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 27, 2026 Filed Jul 29, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 5,000 | $244.96 | $1,224,800.00 |
DisclosureSEC source: 0001193125-26-321680 · ownership.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,604 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $244.95 to $245.29. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 15:39 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 50,913 | $3.64 | $185,323.32 |
DisclosureSEC source: 0001376339-26-000049 · wk-form4_1781278781.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,684 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245808 · ownership.xml · derivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2025 May Restricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239943 · ownership.xml · derivative · entry 2 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239943 · ownership.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 22:41 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 28,609 | $6.47 | $185,100.23 |
DisclosureSEC source: 0001376339-25-000070 · wk-form4_1750718456.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,771 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders Read SEC document |
| May 29, 2025 Filed May 31, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 4,613 | $170.00 | $784,210.00 |
DisclosureSEC source: 0000950170-25-079969 · ownership.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,271 F1 · kind: This transaction is pursuant to a 10b5-1 plan. Read SEC document |
| May 27, 2025 Filed May 29, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 1,551 | $165.72 | $257,031.72 |
DisclosureSEC source: 0000950170-25-078520 · ownership.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,884 F1 · kind: This transaction is pursuant to a 10b5-1 plan. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionRestricted Stock Units · Derivative | 1,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-078013 · ownership.xml · derivative · entry 5 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,551 shares Expires 2025-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 5,000 | $160.00 | $800,000.00 |
DisclosureSEC source: 0000950170-25-078013 · ownership.xml · nonDerivative · entry 3 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,435 F2 · kind: This transaction is pursuant to a 10b5-1 plan. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 8,836 | $159.35 | $1,408,016.60 |
DisclosureSEC source: 0000950170-25-078013 · ownership.xml · nonDerivative · entry 2 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,435 F2 · kind: This transaction is pursuant to a 10b5-1 plan. Read SEC document |
| May 23, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 1,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-078013 · ownership.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 22, 2025 Filed May 28, 2025 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantRestricted Stock Units · Derivative | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-078013 · ownership.xml · derivative · entry 4 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,333 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 F3 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 20:22 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 23,190 | $7.26 | $168,359.40 |
DisclosureSEC source: 0001376339-24-000049 · wk-form4_1717705314.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,162 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders. Read SEC document |
| May 23, 2024 Filed May 29, 2024 00:00 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantRestricted Stock Units · Derivative | 1,551 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065550 · ownership.xml · derivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,551 Underlying: Common Stock · 1,551 shares Expires 2025-05-23 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 22:22 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 35,354 | $4.95 | $175,002.30 |
DisclosureSEC source: 0001376339-23-000042 · wk-form4_1686867744.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,972 F1 · shares: Represents annual restricted stock unit grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 21:21 UTC | Novan, Inc. NOVN · Entity 111882 | Exercise / conversionRestricted Stock Units · Derivative | 36,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001467154-23-000062 · wf-form4_168627369229618.xml · derivative · entry 3 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,101 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The RSUs fully vested on June 7, 2023. F4 · derivative.expiration_date: The RSUs fully vested on June 7, 2023. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 21:21 UTC | Novan, Inc. NOVN · Entity 111882 | Exercise / conversionCommon Stock | 36,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001467154-23-000062 · wf-form4_168627369229618.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person was granted restricted stock units ("RSUs") on June 7, 2022. Each RSU represented a contingent right to receive one share of the Issuer's Common Stock. 36,101 RSUs fully vested on June 7, 2023 and were settled in shares of the Issuer's Common Stock. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:21 UTC | Novan, Inc. NOVN · Entity 111882 | GrantRestricted Stock Units · Derivative | 103,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001467154-23-000062 · wf-form4_168627369229618.xml · derivative · entry 2 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,092 Underlying: Common Stock · 103,092 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service as of the vesting date. F3 · derivative.expiration_date: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service as of the vesting date. Read SEC document |
| May 26, 2023 Filed May 30, 2023 21:09 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 2,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032933 · doc4.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,884 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| May 26, 2023 Filed Jun 23, 2023 22:42 UTC Amendment | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 3,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039515 · doc4a.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,720 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F2 · shares: This amendment is being filed to correct the amount of restricted stock units granted on May 26, 2023. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 17:28 UTC | Novan, Inc. NOVN · Entity 111882 | GrantRestricted Stock Units · Derivative | 36,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001467154-22-000099 · wf-form4_165481010853041.xml · derivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,101 Underlying: Common Stock · 36,101 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs") as the annual award made on the annual meeting date pursuant to the terms of the Issuer's Non-Employee Director Compensation Policy, and each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs. F2 · derivative.expiration_date: The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs. Read SEC document |
| June 07, 2022 Filed Jun 13, 2022 22:31 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 44,191 | $3.96 | $174,996.36 |
DisclosureSEC source: 0001376339-22-000090 · wf-form4_165515945678619.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,618 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders. Read SEC document |
| May 09, 2022 Filed May 11, 2022 20:35 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 3,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028327 · doc4.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,038 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 16:15 UTC | Novan, Inc. NOVN · Entity 111882 | PurchaseCommon Stock | 1,000 | $3.45 | $3,448.80 |
DisclosureSEC source: 0001467154-22-000054 · wf-form4_164970810866280.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 17:23 UTC | Novan, Inc. NOVN · Entity 111882 | PurchaseCommon Stock | 1,000 | $3.45 | $3,450.00 |
DisclosureSEC source: 0001467154-22-000047 · wf-form4_164867536164362.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| March 25, 2022 Filed Mar 28, 2022 17:01 UTC | Novan, Inc. NOVN · Entity 111882 | PurchaseCommon Stock | 2,000 | $3.55 | $7,090.00 |
DisclosureSEC source: 0001467154-22-000045 · wf-form4_164850090320526.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · price: The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $3.49 to $3.60, inclusive. The reporting person undertakes to provide to Novan, Inc., any security holder of Novan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 27, 2021 Filed May 28, 2021 18:22 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 17,056 | $10.26 | $174,994.56 |
DisclosureSEC source: 0001376339-21-000071 · wf-form4_162222615454628.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,427 F1 · kind: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:59 UTC | Novan, Inc. NOVN · Entity 111882 | GrantStock Option (Right to Buy) · Derivative | 8,923 | $0.00 Strike: $9.19 | $0.00 |
DisclosureSEC source: 0001467154-21-000095 · wf-form4_162223556163120.xml · derivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,923 Underlying: Common Stock · 8,923 shares Expires 2031-05-25 F1 · derivative.exercise_date: The option vests in four equal quarterly installments, with the first installment vesting on August 26, 2021. Read SEC document |
| May 07, 2021 Filed May 11, 2021 21:40 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 3,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031792 · doc4.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,202 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| May 04, 2021 Filed May 6, 2021 16:41 UTC | Novan, Inc. NOVN · Entity 111882 | GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001467154-21-000055 · wf-form4_162033364134858.xml · derivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2031-05-03 F1 · derivative.exercise_date: The option vests in four equal quarterly installments, with the first installment vesting on August 4, 2021. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 20:10 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 26,236 | $6.67 | $174,994.12 |
DisclosureSEC source: 0001376339-20-000124 · wf-form4_160192859429819.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,371 F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. Award vests after 12 months. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 08:32 UTC | Novan, Inc. NOVN · Entity 111882 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001467154-20-000142 · wf-form4_160103714221656.xml · derivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-09-22 F1 · derivative.exercise_date: The option vests in four equal quarterly installments, with the first installment vesting on December 23, 2020. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:32 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 38,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-20-000085 · wf-form4_159674591264314.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,135 F1 · security: On August 5, 2020, based on the closing stock price on that date ($5.90), the Company fixed the number of shares of common stock subject to a previously-granted restricted stock unit award. Award vests upon the earlier of one year or the 2019 annual meeting of shareholders, and will be settled in common stock upon vesting. The grant is exempt under Rule 16b-3. F1 · price: On August 5, 2020, based on the closing stock price on that date ($5.90), the Company fixed the number of shares of common stock subject to a previously-granted restricted stock unit award. Award vests upon the earlier of one year or the 2019 annual meeting of shareholders, and will be settled in common stock upon vesting. The grant is exempt under Rule 16b-3. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 23:07 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 11,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033744 · doc4.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,242 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| May 03, 2019 Filed May 7, 2019 21:51 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 10,817 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-028041 · doc4.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,103 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| May 04, 2018 Filed May 8, 2018 20:45 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 7,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-028599 · doc4.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,286 F1 · security: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date and will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 20:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | GrantCommon Stock | 12,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-058901 · doc4.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,847 F1 · security: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 4,552 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 8,295 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). F1 · shares: Represents restricted stock units granted to new non-employee director upon appointment to Board of Directors pursuant to the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. All of these restricted stock units vested immediately on the grant date. 4,552 restricted stock units will be settled in shares of common stock upon termination of service from the Board and 8,295 will be settled in shares of common stock on the third anniversary of the date of grant (unless deferred settlement has been elected). Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:29 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerRestricted Stock Units · Derivative | 3,320 | $43.50 | $144,420.00 |
DisclosureSEC source: 0000899243-17-003194 · doc4.xml · derivative · entry 4 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · kind: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F3 · price: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F6 · derivative.exercise_date: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date. F6 · derivative.expiration_date: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:29 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerRestricted Stock Units · Derivative | 1,630 | $43.50 | $70,905.00 |
DisclosureSEC source: 0000899243-17-003194 · doc4.xml · derivative · entry 3 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,630 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · kind: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F3 · price: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F5 · derivative.exercise_date: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the May 21, 2015 grant date. F5 · derivative.expiration_date: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the May 21, 2015 grant date. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:29 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerRestricted Stock Units · Derivative | 916 | $43.50 | $39,846.00 |
DisclosureSEC source: 0000899243-17-003194 · doc4.xml · derivative · entry 2 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 916 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · kind: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F3 · price: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F4 · derivative.exercise_date: These restricted stock units were to vest on May 20, 2017. F4 · derivative.expiration_date: These restricted stock units were to vest on May 20, 2017. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:29 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerCommon Stock | 19,384 | $43.50 | $843,204.00 |
DisclosureSEC source: 0000899243-17-003194 · doc4.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes. F1 · price: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable withholding taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.